AMNIOX® Medical is the leader in amnion restorative tissue technology and is the first to provide an umbilical cord matrix for transplantation. Our proprietary CRYOTEK™ process is the result of 30 years of National Institute of Health-sponsored research into the unique regenerative biology of these tissues. This process has been proven to preserve the innate functional and structural integrity of the umbilical cord and to maintain the natural hydrated state of the tissue. The clinical success and advantages of the CRYOTEK™ process have been demonstrated in more than 300,000 human transplants and documented in more than 300 peer-reviewed publications. The Respina™ spine products demonstrate clinical performance with the first randomized, controlled, clinical trial in microdiscectomy showing better overall outcomes and a zero recurrent herniation rate at 2 years. The properties of umbilical cord and amniotic membrane modulate the inflammatory process which encourages restorative natural healing versus the typical adult healing model of scarring and adhesion.
Product Categories
Biomaterials
- Stem Cells Biologics
Implants
- Allografts
- Biomaterials
- Disc
Non-fusion
- Annular Repair
Spinal Decompression
- Discectomy
- Foraminotomy/Forminectomy
- Intradiscal injection
- Laminotomy/laminectomy
- Lumbar
Spine Biologics
- Allografts
Wound Management
- Wound Closure